Skip to main content

previous disabled Page of 155
and
  1. Article

    Open Access

    Correction: A positive feedback inhibition of isocitrate dehydrogenase 3β on paired-box gene 6 promotes Alzheimer-like pathology

    **n Wang, Qian Liu, Hai-tao Yu, Jia-zhao **e in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study

    A dose-escalation and expansion, phase 1/2 study (ClinicalTrials.gov, NCT04818333) was conducted to assess the novel antibody-drug conjugate SHR-A1811 in pretreated HER2-altered advanced non-small cell lung ca...

    Ziming Li, Zhengbo Song, Wei Hong, Nong Yang in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

    Patients with intrahepatic cholangiocarcinoma (iCCA) respond poorly to immune checkpoint blockades (ICBs). In this study, we aimed to dissect the potential mechanisms underlying poor response to ICBs and explo...

    Bao-Ye Sun, Dai Zhang, Wei Gan, **g-Fang Wu in Journal of Cancer Research and Clinical On… (2024)

  4. Article

    Open Access

    Correction: A CT based radiomics analysis to predict the CN0 status of thyroid papillary carcinoma: a two- center study

    Zongbao Li, Yifan Zhong, Yan Lv, Jianzhong Zheng, Yu Hu, Yanyan Yang in Cancer Imaging (2024)

  5. Article

    Open Access

    Causal inference of the effect of blood proteome on the risk of head and neck cancer: two-sample Mendelian randomization

    Early diagnosis of head and neck cancer can improve therapeutic outcomes but remains a challenge. The blood proteome can comprise a key source of biomarkers that enable the early diagnosis and precision medici...

    Zhen Wang, Jianhao Wu in Discover Oncology (2024)

  6. Article

    Open Access

    Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high‑volume sarcoma center: a propensity score matching analysis

    Radical resection of retroperitoneal liposarcoma (RLPS) may necessitate vascular resection and reconstruction. The study was conducted to assess surgical outcomes of surgery for RLPS with major vascular involv...

    Guoqiang Xue, **aopeng Wang, Bonan Liu in Journal of Cancer Research and Clinical On… (2024)

  7. Article

    Open Access

    Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression

    Cholangiocarcinoma (CCA), characterized by high heterogeneity and extreme malignancy, has a poor prognosis. Doublecortin-like kinase 1 (DCLK1) promotes a variety of malignant cancers in their progression. Targ...

    Ziwei Liang, Yang Ge, Jianjian Li in Journal of Cancer Research and Clinical On… (2024)

  8. Article

    Open Access

    Effects of the subtypes of apolipoprotein E on immune inhibition and prognosis in patients with Hepatocellular Carcinoma

    To investigate whether prognosis of patients with hepatocellular carcinoma (HCC) is affected by the abundance and subgroups of myeloid-derived suppressor cells (MDSCs) as well as subtypes and expression of apo...

    Bowen Gao, Peiyun Zhou, Li Wang, Zhutao Wang in Journal of Cancer Research and Clinical On… (2024)

  9. Article

    Open Access

    A deep learning-driven discovery of berberine derivatives as novel antibacterial against multidrug-resistant Helicobacter pylori

    Helicobacter pylori (H. pylori) is currently recognized as the primary carcinogenic pathogen associated with gastric tumorigenesis, and its high prevalence and resistance make it difficult to tackle. A graph neur...

    **xi Guo, **aosa Zhao, ** Lu, Li** Zhao in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Efficacy and safety of apatinib plus immune checkpoint inhibitors and transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma

    The evidence of apatinib plus immune checkpoint inhibitors (ICIs) and transarterial chemoembolization (TACE) for treating advanced hepatocellular carcinoma (HCC) is limited. This study aimed to compare the tre...

    Jianfei Wu, Xuefeng Bai, Guodong Yu in Journal of Cancer Research and Clinical On… (2024)

  11. Article

    Open Access

    A cellular senescence-related signature for predicting prognosis, immunotherapy response, and candidate drugs in patients treated with transarterial chemoembolization (TACE)

    Cellular senescence is essential to TME development, progression, and remodeling. Few studies have examined cellular senescence in HCC after TACE. Investigating the relationship between cellular senescence, po...

    Ning He, Wen**g Zhao, Wenlong Tian, Ying Wu, Jian Xu, Yunyan Lu in Discover Oncology (2024)

  12. Article

    Open Access

    Diagnostic efficiency of intravoxel incoherent motion-based virtual magnetic resonance elastography in pulmonary neoplasms

    The aim of the study were as below. (1) To investigate the feasibility of intravoxel incoherent motion (IVIM)-based virtual magnetic resonance elastography (vMRE) to provide quantitative estimates of tissue st...

    Shuo Zhang, Yonghao Du, Ting Liang, Xuyin Zhang, Yinxia Guo, Jian Yang in Cancer Imaging (2024)

  13. Article

    Open Access

    Nasopharyngeal amyloidoma: report of three cases and review of the literature

    Nasopharyngeal amyloidoma is a rare, locally aggressive tumor that has been reported in the English literature in only 38 cases to date, most of which were in the form of case reports. The present study was ai...

    Wangsheng Zuo, Yu Du, Jian-ning Chen in Journal of Cancer Research and Clinical Oncology (2024)

  14. Article

    Open Access

    Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia

    T(8;21)(q22;q22.1)/AML1-ETO positive acute myeloid leukemia (AE-AML) is sensitive to conventional chemotherapy with a favorable prognosis. However, recent small case reports suggest the limited effectiveness o...

    Zhao Yin, Zurong Yao, Dandan Chen, Yu Zhang in Journal of Cancer Research and Clinical On… (2024)

  15. Article

    Open Access

    Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

    The long-term survival benefit of immune checkpoint inhibitors (ICIs) in neoadjuvant and adjuvant settings is unclear for colorectal cancers (CRC) and gastric cancers (GC) with deficiency of mismatch repair (d...

    Zhenghang Wang, Siyuan Cheng, Yanhong Yao, Shengde Liu in Cancer Immunology, Immunotherapy (2024)

  16. Article

    Open Access

    Establishment of a nomogram to predict the overall survival of patients with collecting duct renal cell carcinoma

    Collecting duct carcinoma (CDC) is a rare histological type of renal cell carcinoma that lacks a prognostic prediction model. In this study, we developed a nomogram to predict the prognosis of CDC patients.

    Weixing Jiang, Zuowei Zou, Li Wen in Discover Oncology (2024)

  17. Article

    Open Access

    Lathyrol reduces the RCC invasion and incidence of EMT via affecting the expression of AR and SPHK2 in RCC mice

    To investigate the effects of Lathyrol on the expression of androgen receptor (AR) and sphingosine kinase 2 (SPHK2) in renal cell carcinoma (RCC) mice and to further explore the mechanism by which Lathyrol inh...

    Shengyou Song, Lunwei Tai, Yuqi Xu, Junling Jiang, Lei Zhou in Discover Oncology (2024)

  18. Article

    Open Access

    Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives

    Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death in the world, and hepatocellular carcinoma (HCC) is the most common form of liver cancer. More than half of ...

    Jianzhong Liu, Shuai **a, Baoyi Zhang, Dina Mostafa Mohammed in Discover Oncology (2024)

  19. No Access

    Article

    Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival

    Bexarotene, also recognized as Targretin, is categorized as a retinoid, a type of cancer drug. Nevertheless, the precise mechanisms of bexarotene in relation to colon cancer remain unclear. In colon cancer, SE...

    Huajun Zheng, Jianying Zheng, Yan Shen in Journal of Gastrointestinal Cancer (2024)

  20. Article

    Open Access

    TCBIR/CD320: a potential therapeutic target upregulated in endothelial cells and associated with immune cell infiltration in liver hepatocellular carcinoma

    CD320, which is a transmembrane protein responsible for facilitating the absorption of vitamin B12, plays a key role in this process. However, the relationships between CD320 and immune cell infiltration level...

    Shubin Zhang, Zhongyi Jiang, Pusen Wang, Weihao Jiang, Wei Ding in Discover Oncology (2024)

previous disabled Page of 155